|
US4042699A
(en)
|
1972-12-18 |
1977-08-16 |
Affiliated Medical Research, Inc. |
Method for reducing serum glucose levels
|
|
US4052509A
(en)
|
1972-12-18 |
1977-10-04 |
Affiliated Medical Research, Inc. |
Method for reducing serum uric acid levels
|
|
CA1049411A
(en)
*
|
1972-12-18 |
1979-02-27 |
Affiliated Medical Research |
N-substituted pyridone and general method for preparing pyridones
|
|
DE3404810A1
(de)
|
1984-02-10 |
1985-08-14 |
Siemens AG, 1000 Berlin und 8000 München |
Fensterfunktion fuer ein aperturfenster
|
|
CA1261835A
(en)
|
1984-08-20 |
1989-09-26 |
Masaaki Toda |
(fused) benz(thio)amides
|
|
US4753801A
(en)
|
1985-10-25 |
1988-06-28 |
Eli Lilly And Company |
Sustained release tablets
|
|
US5104648A
(en)
|
1989-02-02 |
1992-04-14 |
Mallinckrodt Specialty Chemicals Company |
High ibuprofen content granulations
|
|
JPH02215719A
(ja)
|
1989-02-15 |
1990-08-28 |
Yamauchi Akitomo |
線維化病変組織の修復並びに線維化病変の阻止剤
|
|
US5275823A
(en)
|
1989-04-27 |
1994-01-04 |
Smith Kline & French Laboratories Ltd. |
Pharmaceutical compositions
|
|
US5310562A
(en)
|
1989-11-22 |
1994-05-10 |
Margolin Solomon B |
Composition and method for reparation and prevention of fibrotic lesions
|
|
US5716632A
(en)
|
1989-11-22 |
1998-02-10 |
Margolin; Solomon B. |
Compositions and methods for reparation and prevention of fibrotic lesions
|
|
US5518729A
(en)
|
1989-11-22 |
1996-05-21 |
Margolin; Solomon B. |
Compositions and methods for reparation and prevention of fibrotic lesions
|
|
US5861172A
(en)
|
1991-05-08 |
1999-01-19 |
Laboratorios Beecham Sa |
Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
|
|
AU1193092A
(en)
|
1992-01-10 |
1993-08-03 |
Obschestvo S Ogranichennoi Otvetstvennostju Meditsinsky Nauchno-Proizvodstvenny Komplex Biotiki |
Granulated pharmaceutical composition and method of obtaining it
|
|
NZ251806A
(en)
|
1992-04-15 |
1996-01-26 |
Marion Merrell Dow Inc |
Making compressed tablets containing aminoguanidine or a salt thereof and a binder, by first spray-drying an aqueous solution to form a powder
|
|
ATE180668T1
(de)
|
1992-12-01 |
1999-06-15 |
Spirig Ag |
S(+)-ibuprofen enthaltende arzneimittel
|
|
JPH08510251A
(ja)
|
1993-05-07 |
1996-10-29 |
ビー マーゴリン、ソロモン |
線維症の病変の修復と予防のための組成物および方法
|
|
EP0716597A1
(en)
|
1993-08-30 |
1996-06-19 |
Warner-Lambert Company |
Tablet coating based on a melt-spun mixture of a saccharide and apolymer
|
|
US5591766A
(en)
|
1993-12-03 |
1997-01-07 |
Cheil Foods & Chemicals, Inc. |
Solid oral formulations of pyridone carboxylic acids
|
|
GB9325644D0
(en)
|
1993-12-15 |
1994-02-16 |
Smithkline Beecham Plc |
Novel formulation
|
|
US5639754A
(en)
|
1994-07-12 |
1997-06-17 |
Janssen Pharmaceutica N.V. |
Urea and thiourea derivatives of azolones
|
|
RU2165423C2
(ru)
|
1994-10-07 |
2001-04-20 |
Фудзисава Фармасьютикал Ко., Лтд. |
Полипептидное соединение, способ его получения и фармацевтическая композиция
|
|
US6395303B1
(en)
|
1996-06-10 |
2002-05-28 |
Edward Mendell Co., Inc. |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
|
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
|
GB9501127D0
(en)
|
1995-01-20 |
1995-03-08 |
Wellcome Found |
Tablet
|
|
US6090822A
(en)
|
1995-03-03 |
2000-07-18 |
Margolin; Solomon B. |
Treatment of cytokine growth factor caused disorders
|
|
EP0837052B1
(en)
|
1995-06-21 |
2006-08-23 |
Shionogi & Co., Ltd. |
Bicyclic amino derivatives and pgd 2 antagonist containing the same
|
|
US5681382A
(en)
|
1995-08-22 |
1997-10-28 |
Shin-Etsu Chemical Co., Ltd. |
Rapidly soluble coating composition and method for preparing same
|
|
EP0866656B1
(en)
|
1995-09-19 |
2007-04-25 |
MARGOLIN, Solomon B. |
Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors
|
|
US5962478A
(en)
|
1995-09-19 |
1999-10-05 |
Margolin; Solomon B. |
Inhibition of tumor necrosis factor α
|
|
US6852336B2
(en)
|
1995-11-15 |
2005-02-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Directly compressible high load acetaminophen formulations
|
|
US6348216B1
(en)
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
|
DE19628617A1
(de)
|
1996-07-16 |
1998-01-22 |
Basf Ag |
Direkttablettierhilfsmittel
|
|
US7179486B1
(en)
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
|
TW580397B
(en)
|
1997-05-27 |
2004-03-21 |
Takeda Chemical Industries Ltd |
Solid preparation
|
|
EP0901787B1
(en)
|
1997-09-10 |
2003-05-28 |
Takeda Chemical Industries, Ltd. |
Stabilized pharmaceutical composition
|
|
DK2263660T3
(en)
|
1998-05-18 |
2018-01-02 |
Takeda Pharmaceuticals Co |
Orally disintegrating tablets.
|
|
DK1083885T3
(da)
|
1998-06-11 |
2007-02-26 |
Pharmacia & Upjohn Co Llc |
Delavirdintabletformulering
|
|
US6117451A
(en)
|
1998-08-25 |
2000-09-12 |
Pharmalogix, Inc. |
Direct compression metformin hydrochloride tablets
|
|
US6599530B2
(en)
|
1998-09-14 |
2003-07-29 |
Orion Corporation |
Oral compacted composition comprising catechol derivatives
|
|
IT1311907B1
(it)
|
1999-04-06 |
2002-03-20 |
Zambon Spa |
Compresse deglutibili ad alto contenuto di n-acetilcisteina.
|
|
US6262072B1
(en)
|
1999-10-12 |
2001-07-17 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Orally administered antimicrobial pharmaceutical formulations of ciprofloxacin
|
|
DK1235558T3
(da)
|
1999-12-09 |
2006-10-09 |
Reckitt Benckiser Healthcare |
Sammenpresset tabletsammensætning, der omfatter et NSAID
|
|
US6956044B1
(en)
|
2000-02-21 |
2005-10-18 |
Margolin Solomon B |
Compositions and methods for treatment of epilepsy
|
|
PL365072A1
(en)
|
2000-03-07 |
2004-12-27 |
Ranbaxy Laboratories Limited |
Azole compounds as therapeutic agents for fungal infections
|
|
AU4278301A
(en)
|
2000-03-27 |
2001-10-08 |
Kyowa Hakko Kogyo Co. Ltd. |
Easy-to-take granule
|
|
JP2004525071A
(ja)
|
2000-07-20 |
2004-08-19 |
ニューロジェン コーポレイション |
カプサイシン受容体リガンド
|
|
EP1319409A4
(en)
|
2000-09-22 |
2006-05-03 |
Takeda Pharmaceutical |
SOLID PREPARATIONS
|
|
KR100891887B1
(ko)
|
2001-01-29 |
2009-04-03 |
시오노기세이야쿠가부시키가이샤 |
5-메틸-1-페닐-2-(1ｈ)-피리돈을 활성 성분으로서 함유하는의약 제제
|
|
PE20021081A1
(es)
|
2001-04-12 |
2002-12-18 |
Pharmacopeia Drug Discovery |
Aril y biaril piperidinas con actividad moduladora mch
|
|
JP4280074B2
(ja)
|
2001-04-25 |
2009-06-17 |
大正製薬株式会社 |
マルチプルユニット型徐放性錠剤
|
|
US6761905B2
(en)
|
2001-05-01 |
2004-07-13 |
Wei Ming Pharmaceutical Mfg. Co., Ltd. |
Process for the preparation of direct tabletting formulations and aids
|
|
CA2468015A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
2-aminoquinoline compounds
|
|
WO2003066595A2
(en)
|
2002-02-01 |
2003-08-14 |
Euro-Celtique S.A. |
2 - piperazine - pyridines useful for treating pain
|
|
US6974818B2
(en)
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
|
GB0209265D0
(en)
|
2002-04-23 |
2002-06-05 |
Novartis Ag |
Organic compounds
|
|
WO2003105809A1
(en)
|
2002-06-17 |
2003-12-24 |
Themis Laboratories Private Limited |
Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
|
|
PT1556354E
(pt)
|
2002-06-28 |
2008-04-17 |
Euro Celtique Sa |
Derivados de piperazina úteis como agentes terapêuticos para o tratamento da dor
|
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
AU2003262811A1
(en)
|
2002-08-27 |
2004-03-19 |
Intermune, Inc. |
Methods of treating idiopathic pulmonary fibrosis
|
|
EP1551369A4
(en)
|
2002-08-28 |
2007-05-09 |
Intermune Inc |
COMBINATION THERAPY FOR THE TREATMENT OF FIBROTIC DISEASES
|
|
US7157462B2
(en)
|
2002-09-24 |
2007-01-02 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
EP1551811A1
(en)
|
2002-10-17 |
2005-07-13 |
Amgen Inc. |
Benzimidazole derivatives and their use as vanilloid receptor ligands
|
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
JP4542743B2
(ja)
|
2002-12-26 |
2010-09-15 |
Ｋｄｌ株式会社 |
ピリドン誘導体の溶液状医薬組成物
|
|
WO2004075826A2
(en)
|
2003-02-28 |
2004-09-10 |
Ranbaxy Laboratories Limited |
Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
|
|
HRP20050902A2
(en)
|
2003-03-31 |
2005-12-31 |
Pliva-Lachema A.S. |
Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof
|
|
AU2003236336A1
(en)
|
2003-04-01 |
2004-11-01 |
Ohara Chmical Industries, Ltd. |
Process for producing tablet
|
|
US8507000B2
(en)
|
2003-05-06 |
2013-08-13 |
Nostrum Pharmaceuticals, Inc. |
Controlled release formulation of erythromycin derivatives
|
|
US20050008691A1
(en)
|
2003-05-14 |
2005-01-13 |
Arturo Siles Ortega |
Bicalutamide compositions
|
|
US20070092488A1
(en)
|
2003-05-16 |
2007-04-26 |
Intermune Inc. |
Methods of treating idiopathic pulmonary fibrosis
|
|
CN101039957A
(zh)
|
2003-05-16 |
2007-09-19 |
因特缪恩公司 |
合成的趋化因子受体配体及其使用方法
|
|
HUP0301537A3
(en)
|
2003-06-03 |
2005-07-28 |
Egis Gyogyszergyar Nyilvanosan |
Deramcyclane fumarate tablets and process for producing them
|
|
MY142655A
(en)
|
2003-06-12 |
2010-12-15 |
Euro Celtique Sa |
Therapeutic agents useful for treating pain
|
|
CA2531116A1
(en)
|
2003-07-01 |
2005-01-20 |
Michael Hawley |
Diffusion layer modulated solids
|
|
US7632521B2
(en)
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
|
SI1867644T1
(sl)
|
2003-07-24 |
2009-10-31 |
Euro Celtique Sa |
Heteroaril-tetrahidropiperidilne spojine, koristne za zdravljenje ali preprečevanje bolečine
|
|
AU2004259357B2
(en)
|
2003-07-24 |
2010-02-18 |
Euro-Celtique S.A. |
Piperidine compounds and pharmaceutical compositions containing them
|
|
PL1942106T3
(pl)
|
2003-08-01 |
2012-02-29 |
Euro Celtique Sa |
Środki lecznicze użyteczne do leczenia bólu
|
|
PL1664016T3
(pl)
|
2003-09-22 |
2009-04-30 |
Euro Celtique Sa |
Środki terapeutyczne przydatne do leczenia bólu
|
|
EP1664041B1
(en)
|
2003-09-22 |
2008-07-02 |
Euro-Celtique S.A. |
Phenyl-carboxamide compounds useful for treating pain
|
|
US20050079221A1
(en)
|
2003-10-10 |
2005-04-14 |
Groenewoud Pieter Jurjen |
Ibuprofen narcotic composition and method for making same
|
|
WO2005039598A1
(en)
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Method of treating alcoholic liver disease
|
|
US7407973B2
(en)
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
|
JP4614884B2
(ja)
|
2003-11-14 |
2011-01-19 |
シャンハイ ゲノミックス インク |
ピリドンの誘導体とその使用
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
ES2322907T3
(es)
|
2003-12-30 |
2009-07-01 |
Euro-Celtique S.A. |
Piperazinas utiles para el tratamiento de dolor.
|
|
SE0400235D0
(sv)
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
|
US8642079B2
(en)
|
2004-02-23 |
2014-02-04 |
Hormos Medical Corporation |
Solid formulations of ospemifene
|
|
US7605176B2
(en)
|
2004-03-06 |
2009-10-20 |
Boehringer Ingelheim International Gmbh |
β-ketoamide compounds with MCH antagonistic activity
|
|
MY148773A
(en)
|
2004-03-17 |
2013-05-31 |
Novartis Ag |
Galenic formulations of organic compounds
|
|
MY149038A
(en)
|
2004-05-26 |
2013-07-15 |
Eisai R&D Man Co Ltd |
Cinnamide compound
|
|
BRPI0511663A
(pt)
|
2004-06-07 |
2008-01-02 |
Wyeth Corp |
composição compreendendo água e um componente de sólidos, processo, e, tablete revestido
|
|
BRPI0512900A
(pt)
|
2004-06-30 |
2008-04-15 |
Albemarle Corp |
composição farmacêutica compreendendo de ibuprofeno, processo de preparação dos gránulos enriquecidos em ibuprofeno e os gránulos secos feitos por este processo
|
|
EA014249B1
(ru)
|
2005-01-27 |
2010-10-29 |
Алембик Лимитед |
Формуляция леветирацетама длительного высвобождения
|
|
DE602006001295D1
(de)
|
2005-02-03 |
2008-07-03 |
Nycomed Pharma As |
Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
|
|
US20070009591A1
(en)
|
2005-07-07 |
2007-01-11 |
Trivedi Jay S |
ACE inhibitor formulation
|
|
AU2006276246B2
(en)
|
2005-07-25 |
2012-09-27 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis C virus replication
|
|
NZ591443A
(en)
*
|
2005-09-22 |
2013-04-26 |
Intermune Inc |
Granule formation of pirfenidone and pharmaceutically acceptable excipients
|
|
US20070203202A1
(en)
|
2005-12-02 |
2007-08-30 |
Robinson Cynthia Y |
Methods of reducing adverse events associated with pirfenidone therapy
|
|
WO2007069773A1
(en)
|
2005-12-15 |
2007-06-21 |
Shionogi & Co., Ltd. |
A pharmaceutical composition comprising an amide derivative
|
|
AU2006335344A1
(en)
|
2006-01-11 |
2007-07-19 |
Teva Pharmaceutical Industries Ltd. |
Controlled release formulation of divalproic acid and its derivatives
|
|
ZA200807571B
(en)
|
2006-03-01 |
2009-08-26 |
Ethypharm Sa |
Crush-resistant tablets intended to prevent accidental misuse and unlawful diversion
|
|
CZ300698B6
(cs)
|
2006-06-16 |
2009-07-22 |
Zentiva, A. S. |
Tableta s obsahem metforminu
|
|
JP5475443B2
(ja)
|
2006-06-28 |
2014-04-16 |
エミスフェアー・テクノロジーズ・インク |
硝酸ガリウム製剤
|
|
US20080254118A1
(en)
|
2007-04-11 |
2008-10-16 |
Hans-Werner Wernersbach |
Process for preparing pramipexole dihydrochloride tablets
|
|
WO2008062446A2
(en)
|
2006-09-14 |
2008-05-29 |
Alembic Limited |
An extended release composition of levetiracetam, which exhibits no adverse food effect
|
|
CA2563690C
(en)
|
2006-10-12 |
2014-10-07 |
Pharmascience Inc. |
Pharmaceutical compositions comprising intra- and extra- granular fractions
|
|
US8951562B2
(en)
|
2006-11-10 |
2015-02-10 |
Atacama Labs Oy |
Method and apparatus or dry granulation
|
|
SI2124945T1
(sl)
|
2006-12-18 |
2011-08-31 |
Intermune Inc |
Postopek dajanja terapije s pirfenidonom pacientu
|
|
EP1952803A1
(en)
|
2007-01-23 |
2008-08-06 |
KTB-Tumorforschungs GmbH |
Solid pharmaceutical dosage form containing hydrogenated phospholipids
|
|
DK2142529T3
(da)
|
2007-04-27 |
2014-02-10 |
Purdue Pharma Lp |
Trpv1-antagonister og anvendelser deraf
|
|
WO2008133973A1
(en)
|
2007-04-27 |
2008-11-06 |
Purdue Pharma L.P. |
Therapeutic agents useful for treating pain
|
|
EP1987814A1
(en)
|
2007-04-30 |
2008-11-05 |
Exelgyn |
Mifepristone pharmaceutical compositions and their methods of preparation
|
|
US20080287508A1
(en)
|
2007-05-18 |
2008-11-20 |
Intermune, Inc. |
Altering pharmacokinetics of pirfenidone therapy
|
|
JP5587184B2
(ja)
|
2007-06-20 |
2014-09-10 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
繊維症阻害剤としての置換ｎ−アリールピリジノン
|
|
SI2178513T1
(sl)
|
2007-06-22 |
2011-05-31 |
Bristol Myers Squibb Co |
Tabletni sestavki vsebujoäśi atazanavir
|
|
ES2360336T3
(es)
|
2007-06-22 |
2011-06-03 |
Bristol-Myers Squibb Company |
Composiciones en comprimidos que contienen atazanavir.
|
|
DK2170292T3
(da)
|
2007-06-22 |
2014-04-07 |
Bristol Myers Squibb Holdings Ireland |
Atazanavirholdige sammensætninger i tabletform
|
|
US20090131485A1
(en)
|
2007-09-10 |
2009-05-21 |
Concert Pharmaceuticals, Inc. |
Deuterated pirfenidone
|
|
MY169761A
(en)
|
2007-11-07 |
2019-05-15 |
Rigel Pharmaceuticals Inc |
Wet granulation using a water sequestering agent
|
|
EP2276734A1
(en)
|
2008-04-17 |
2011-01-26 |
Pfizer Inc. |
4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
|
|
ES2617619T3
(es)
|
2008-06-05 |
2017-06-19 |
Janssen Pharmaceutica, N.V. |
Combinaciones de fármacos que comprenden un inhibidor de DGAT y un agonista de PPAR
|
|
GB2460915B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
|
|
GB0813929D0
(en)
|
2008-07-30 |
2008-09-03 |
Glaxo Group Ltd |
Novel method
|
|
WO2010035282A1
(en)
|
2008-09-24 |
2010-04-01 |
Matrix Laboratories Limited |
Pharmaceutical compositions comprising deferasirox
|
|
US8546388B2
(en)
|
2008-10-24 |
2013-10-01 |
Purdue Pharma L.P. |
Heterocyclic TRPV1 receptor ligands
|
|
US8759362B2
(en)
|
2008-10-24 |
2014-06-24 |
Purdue Pharma L.P. |
Bicycloheteroaryl compounds and their use as TRPV1 ligands
|
|
US8703962B2
(en)
|
2008-10-24 |
2014-04-22 |
Purdue Pharma L.P. |
Monocyclic compounds and their use as TRPV1 ligands
|
|
WO2010048716A1
(en)
|
2008-10-29 |
2010-05-06 |
Pacific Therapeutics Ltd. |
Composition and method for treating fibrosis
|
|
US8778398B2
(en)
|
2008-11-04 |
2014-07-15 |
Jazz Pharmaceuticals, Inc. |
Immediate release formulations and dosage forms of gamma-hydroxybutyrate
|
|
US7566729B1
(en)
|
2008-11-10 |
2009-07-28 |
Intermune, Inc. |
Modifying pirfenidone treatment for patients with atypical liver function
|
|
US7635707B1
(en)
|
2008-11-10 |
2009-12-22 |
Intermune, Inc. |
Pirfenidone treatment for patients with atypical liver function
|
|
US20100166861A1
(en)
|
2008-12-29 |
2010-07-01 |
Kelly Noel Lynch |
Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone
|
|
US8513261B2
(en)
|
2009-03-13 |
2013-08-20 |
Toyama Chemical Co., Ltd. |
Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
|
|
WO2010135470A1
(en)
|
2009-05-19 |
2010-11-25 |
Intermune, Inc. |
Pifenidone derivatives for treating bronchial asthma
|
|
TWI434833B
(zh)
|
2009-06-03 |
2014-04-21 |
Intermune Inc |
用於合成吡非尼酮（ｐｉｒｆｅｎｉｄｏｎｅ）的改良方法
|
|
CN101921225B
(zh)
|
2009-06-11 |
2013-04-03 |
北京凯得尔森生物技术有限公司 |
吡啡尼酮类化合物、其制备方法和应用
|
|
AU2010316683B2
(en)
*
|
2009-11-09 |
2015-10-08 |
Wyeth Llc |
Tablet formulations of neratinib maleate
|
|
US7816383B1
(en)
|
2009-12-04 |
2010-10-19 |
Intermune, Inc. |
Methods of administering pirfenidone therapy
|
|
US8084475B2
(en)
|
2009-12-04 |
2011-12-27 |
Intermune, Inc. |
Pirfenidone therapy and inducers of cytochrome P450
|
|
EP2338474A1
(de)
*
|
2009-12-23 |
2011-06-29 |
Ratiopharm GmbH |
Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
|
|
IL210279A0
(en)
|
2009-12-25 |
2011-03-31 |
Dexcel Pharma Technologies Ltd |
Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients
|
|
EP2359814A1
(en)
|
2010-02-11 |
2011-08-24 |
Laboratorios Liconsa, S.A. |
Pharmaceutical mini-tablets for sustained release of flecainide acetate
|
|
EP2552447A4
(en)
|
2010-03-29 |
2013-09-11 |
Hetero Research Foundation |
STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB
|
|
WO2011162409A1
(en)
|
2010-06-22 |
2011-12-29 |
Shionogi & Co., Ltd. |
Compounds having trpv1 antagonistic activity and uses thereof
|
|
WO2012029074A2
(en)
|
2010-09-02 |
2012-03-08 |
Hetero Research Foundation |
Pharmaceutical compositions of linezolid
|
|
CN101972236A
(zh)
|
2010-10-13 |
2011-02-16 |
北京诚创康韵医药科技有限公司 |
一种含吡非尼酮的缓释制剂
|
|
TR201011148A1
(tr)
|
2010-12-30 |
2012-07-23 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Levetirasetam farmasötik bileşimleri.
|
|
EP2663283B1
(en)
|
2011-01-14 |
2017-05-10 |
Bristol-Myers Squibb Company |
High drug load tablet formulation of brivanib alaninate
|
|
US10105356B2
(en)
|
2011-01-31 |
2018-10-23 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
|
WO2012114352A2
(en)
|
2011-02-21 |
2012-08-30 |
Hetero Research Foundation |
Pharmaceutical compositions of maraviroc and process for the preparation thereof
|
|
JP2014507474A
(ja)
|
2011-03-08 |
2014-03-27 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換ｎ−アリールピリジノン
|
|
MX2011007675A
(es)
|
2011-07-19 |
2012-07-11 |
Cell Therapy And Technology S A De C V |
Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
|
|
WO2013022924A1
(en)
|
2011-08-08 |
2013-02-14 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical formulations
|
|
CN102846555B
(zh)
*
|
2012-04-09 |
2014-06-25 |
珠海亿邦制药股份有限公司 |
一种以吡非尼酮为活性成分的固体制剂及其应用
|
|
KR102121082B1
(ko)
|
2012-04-20 |
2020-06-10 |
디에스엠 아이피 어셋츠 비.브이. |
색 안정성을 갖는 고형 l-아스코르브산 조성물
|
|
US20150224086A1
(en)
|
2012-08-23 |
2015-08-13 |
Hetero Research Foundation |
Pharmaceutical Formulations of Rufinamide
|
|
CA2819967C
(en)
|
2012-08-31 |
2016-03-22 |
Intermune, Inc. |
Use of pirfenidone concomitantly with ciprofloxacin
|
|
CN102846569A
(zh)
|
2012-09-06 |
2013-01-02 |
北京万全德众医药生物技术有限公司 |
一种含吡非尼酮的药物组合物及其制备方法
|
|
EA032913B1
(ru)
|
2012-10-18 |
2019-08-30 |
Эббви Инк. |
Препараты производных пиримидиндиона
|
|
BR112014027231A2
(pt)
|
2013-01-15 |
2017-06-27 |
Fujifilm Corp |
comprimido contendo 5-hidróxi-1h-imidazola-4-carboxamida
|
|
WO2014115082A1
(en)
|
2013-01-22 |
2014-07-31 |
Dr. Reddys Laboratories Limited |
Pharmaceutical formulations of imatinib
|
|
EP2958563A2
(en)
|
2013-02-20 |
2015-12-30 |
AbbVie Inc. |
Tablet dosage form comprising ritonavir and lopinavir
|
|
ME03297B
(me)
|
2013-03-08 |
2019-07-20 |
Novartis Ag |
Oralne formulacije deferasiroksa
|
|
GB201304699D0
(en)
|
2013-03-15 |
2013-05-01 |
Remedica Ltd |
Pharmaceutical compositions
|
|
CN103271886B
(zh)
|
2013-05-29 |
2014-08-13 |
南京正大天晴制药有限公司 |
一种吡非尼酮片剂及其制备方法
|
|
HK1220390A1
(zh)
|
2013-08-29 |
2017-05-05 |
Teva Pharmaceutical Industries Ltd. |
包括恩曲他滨，替诺福韦，达芦那韦和利托那韦的单位剂型以及包含达芦那韦和利托那韦的单体片剂
|
|
WO2015040093A1
(en)
|
2013-09-20 |
2015-03-26 |
Dsm Sinochem Pharmaceuticals Netherlands B.V. |
Tablet comprising crospovidone
|
|
KR102286386B1
(ko)
|
2013-10-07 |
2021-08-05 |
브리스톨-마이어스 스퀴브 홀딩스 아일랜드 언리미티드 컴퍼니 |
아타자나비르 및 코비시스타트의 ｈｉｖ 치료 제제
|
|
IL310920A
(en)
|
2015-01-27 |
2024-04-01 |
Janssen Pharmaceutica Nv |
Dispersible compositions
|